Soumit Roy
Stock Analyst at Jones Trading
(2.78)
# 1,657
Out of 5,172 analysts
46
Total ratings
30.56%
Success rate
12.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine | Upgrades: Buy | $8 | $2.34 | +241.88% | 2 | Mar 10, 2026 | |
| DAWN Day One Biopharmaceuticals | Downgrades: Hold | $20 → $22 | $21.44 | +0.28% | 1 | Mar 6, 2026 | |
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $3.59 | +94.99% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $2.88 | +143.06% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $3.91 | +155.75% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $4.06 | - | 1 | Oct 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Hold | n/a | $0.81 | - | 2 | Sep 15, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $65.08 | -23.17% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $5.21 | +303.07% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $22.02 | +81.65% | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $27 | $29.03 | -6.99% | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.66 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.95 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $4.02 | +273.13% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.22 | +136.97% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $24.63 | +38.04% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $2.00 | +1,700.00% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $4.19 | +663.72% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $10.85 | -17.05% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $11.16 | +52.33% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $6.92 | +824.86% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.76 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $12.74 | +104.08% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $14.06 | +397.87% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $55.21 | -81.89% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.03 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $11.30 | +607.96% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.80 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $0.74 | +43,231.08% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $6.52 | +12,323.31% | 1 | Feb 24, 2021 |
Editas Medicine
Mar 10, 2026
Upgrades: Buy
Price Target: $8
Current: $2.34
Upside: +241.88%
Day One Biopharmaceuticals
Mar 6, 2026
Downgrades: Hold
Price Target: $20 → $22
Current: $21.44
Upside: +0.28%
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $3.59
Upside: +94.99%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.88
Upside: +143.06%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $3.91
Upside: +155.75%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $4.06
Upside: -
aTyr Pharma
Sep 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.81
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $65.08
Upside: -23.17%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $5.21
Upside: +303.07%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $22.02
Upside: +81.65%
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $29.03
Upside: -6.99%
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.66
Upside: -
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.95
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $4.02
Upside: +273.13%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $4.22
Upside: +136.97%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $24.63
Upside: +38.04%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $2.00
Upside: +1,700.00%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $4.19
Upside: +663.72%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $10.85
Upside: -17.05%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $11.16
Upside: +52.33%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $6.92
Upside: +824.86%
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.76
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $12.74
Upside: +104.08%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $14.06
Upside: +397.87%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $55.21
Upside: -81.89%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.03
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $11.30
Upside: +607.96%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.80
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $0.74
Upside: +43,231.08%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $6.52
Upside: +12,323.31%